Research Article
Frequency and Spectrum of KRAS Mutations in Moroccan Patients with Lung Adenocarcinoma
Table 2
Patient characteristics by KRAS mutation status.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P value calculated by t-test. ** P value calculated by Fisher’s exact test. |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P value calculated by t-test. ** P value calculated by Fisher’s exact test. |